Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
In the latest session, Rockwell Medical Inc (NASDAQ: RMTI) closed at $1.20 down -4.76% from its previous closing price of $1.26. In other words, the price has decreased by -$4.76 from its previous closing price. On the day, 0.58 million shares were traded. RMTI stock price reached its highest trading level at $1.2954 during the session, while it also had its lowest trading level at $1.18.
Ratios:
For a deeper understanding of Rockwell Medical Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.89 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 12.81. For the most recent quarter (mrq), Quick Ratio is recorded 2.22 and its Current Ratio is at 2.63. In the meantime, Its Debt-to-Equity ratio is 0.42 whereas as Long-Term Debt/Eq ratio is at 0.34.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on November 14, 2024, initiated with a Buy rating and assigned the stock a target price of $5.
On June 24, 2019, Piper Jaffray started tracking the stock assigning a Overweight rating and target price of $10.
On May 13, 2019, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $11.H.C. Wainwright initiated its Buy rating on May 13, 2019, with a $11 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 02 ’25 when Chole Timothy sold 1,001 shares for $2.05 per share. The transaction valued at 2,052 led to the insider holds 54,170 shares of the business.
Strobeck Mark sold 2,163 shares of RMTI for $4,445 on Jan 02 ’25. The President and CEO now owns 145,038 shares after completing the transaction at $2.06 per share. On Jan 02 ’25, another insider, Strobeck Mark, who serves as the Officer of the company, bought 2,163 shares for $2.06 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RMTI now has a Market Capitalization of 42911760 and an Enterprise Value of 32801304. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.40 while its Price-to-Book (P/B) ratio in mrq is 1.25. Its current Enterprise Value per Revenue stands at 0.323 whereas that against EBITDA is 11.765.
Stock Price History:
The Beta on a monthly basis for RMTI is 1.57, which has changed by -0.26829267 over the last 52 weeks, in comparison to a change of 0.10063088 over the same period for the S&P500. Over the past 52 weeks, RMTI has reached a high of $5.15, while it has fallen to a 52-week low of $1.26. The 50-Day Moving Average of the stock is -34.00%, while the 200-Day Moving Average is calculated to be -51.26%.
Shares Statistics:
For the past three months, RMTI has traded an average of 282.78K shares per day and 417670 over the past ten days. A total of 34.06M shares are outstanding, with a floating share count of 29.51M. Insiders hold about 13.36% of the company’s shares, while institutions hold 24.32% stake in the company. Shares short for RMTI as of 1740700800 were 459975 with a Short Ratio of 1.63, compared to 1738281600 on 504200. Therefore, it implies a Short% of Shares Outstanding of 459975 and a Short% of Float of 1.43.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
